<DOC>
	<DOCNO>NCT03090399</DOCNO>
	<brief_summary>In retrospective analysis investigator study effect use minimally invasive hemodynamic monitoring ( FloTrac-Edwards ) postoperative outcome . Participants compare control group case group ; group ASA 1 patient suffer advanced ovarian cancer underwent radical cytoreductive surgery . In case group hemodynamic manage use FloTrac system ; control group standard hemodynamic monitoring use .</brief_summary>
	<brief_title>Fluid ORiented Therapy yoUNg Asa 1patients</brief_title>
	<detailed_description />
	<criteria>ASA 1 cardiac disease pulmonary disease renal disease metabolic disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Goal Directed Fluid Therapy</keyword>
</DOC>